Yvonne Y. Lau, Ph.D. - Publications
Affiliations: | 2006 | University of California, San Francisco, San Francisco, CA |
Area:
Pharmacy, Animal Physiology BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2007 | Lau YY, Huang Y, Frassetto L, Benet LZ. effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clinical Pharmacology and Therapeutics. 81: 194-204. PMID 17192770 DOI: 10.1038/Sj.Clpt.6100038 | 0.473 | |||
2006 | Lau YY, Okochi H, Huang Y, Benet LZ. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 1175-81. PMID 16624870 DOI: 10.1124/Dmd.105.009076 | 0.514 | |||
2006 | Lau YY, Okochi H, Huang Y, Benet LZ. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. The Journal of Pharmacology and Experimental Therapeutics. 316: 762-71. PMID 16258024 DOI: 10.1124/Jpet.105.093088 | 0.522 | |||
2006 | Lau YY, Okochi H, Huang Y, Benet LZ. Response to comments on "multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: Application of in vitro and ex situ systems" [2] Journal of Pharmacology and Experimental Therapeutics. 316: 1387. DOI: 10.1124/jpet.105.099473 | 0.4 | |||
2004 | Lau YY, Wu CY, Okochi H, Benet LZ. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. The Journal of Pharmacology and Experimental Therapeutics. 308: 1040-5. PMID 14634033 DOI: 10.1124/Jpet.103.061770 | 0.494 | |||
Show low-probability matches. |